Kim Berentsen

4.3k total citations
2 papers, 31 citations indexed

About

Kim Berentsen is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kim Berentsen has authored 2 papers receiving a total of 31 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Pharmacology, 1 paper in Pulmonary and Respiratory Medicine and 1 paper in Oncology. Recurrent topics in Kim Berentsen's work include HER2/EGFR in Cancer Research (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Advanced Breast Cancer Therapies (1 paper). Kim Berentsen is often cited by papers focused on HER2/EGFR in Cancer Research (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Advanced Breast Cancer Therapies (1 paper). Kim Berentsen collaborates with scholars based in . Kim Berentsen's co-authors include Ebo Bos, David Egging, Eline M. Loosveld, Olivier Raguin, I. Janssen, Wim H.A. Dokter, Ruud Ubink, Patrick G. Groothuis, Francis Bichat and Miranda M.C. van der Lee and has published in prestigious journals such as Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Kim Berentsen

2 papers receiving 29 citations

Peers

Kim Berentsen

RNMI

ONCOL

MB

OC

CR

Leanna R. Staben China

Neelie T. Zacharias

Lorenzo Buroni United Kingdom

Pamela Woodings United Kingdom

A. Nogueira-Rodrigues Brazil

Osman Mahamud Canada

Jose Saro Switzerland

Marivic Ricamara United Kingdom

B. Diorio United States

Tina Weinzierl Switzerland

Leanna R. Staben China

Kim Berentsen

21 ×1.0

RNMI

26 ×1.4

ONCOL

20 ×1.8

MB

9 ×3.0

OC

1 ×0.3

CR

Citations per year, relative to Kim Berentsen Kim Berentsen (= 1×) peers Leanna R. Staben

Countries citing papers authored by Kim Berentsen

Since Specialization

Citations

This map shows the geographic impact of Kim Berentsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Berentsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Berentsen more than expected).

Fields of papers citing papers by Kim Berentsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Berentsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Berentsen. The network helps show where Kim Berentsen may publish in the future.

Co-authorship network of co-authors of Kim Berentsen

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Berentsen. A scholar is included among the top collaborators of Kim Berentsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Berentsen. Kim Berentsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Groothuis, Patrick G., Daniëlle C.H. Jacobs, Kim Berentsen, et al.. (2021). Abstract 925: Introduction to the preclinical profile of SYD1875, a novel site-specifically conjugated duocarmycin-based 5T4-targeting antibody-drug conjugate. Cancer Research. 81(13_Supplement). 925–925. 3 indexed citations

2.

Ubink, Ruud, Ebo Bos, I. Janssen, et al.. (2018). Unraveling the Interaction between Carboxylesterase 1c and the Antibody–Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice. Molecular Cancer Therapeutics. 17(11). 2389–2398. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact